Press releases, peer-reviewed publications, conference presentations, and leadership commentary as Trevarx advances toward IND and first-in-human trials.
Blog
The Next Advance in Cancer Radiation Treatment Is Not Power. It Is Geometry.
Trevarx Biomedical is developing investigational product candidates. Trevarx’s product candidates, including AlphaPARP and PARPTrace, have not been approved by FDA or any other regulatory authority, and their safety and efficacy have not been established. This website is for informational purposes only and does not provide medical advice, offer securities, or promote any investigational product.
